Best, C.H.: Preparation of heparin and its use in the first clinical cases. Circulation, 19: 79, 1959.
2.
Butt, H.R., Allen, E.V., AND Bollman, J.L.: Preparation from spoiled sweetclover (3,3'-methylene-bis-4-hydroxycoumarin) which prolongs the coagulation and prothrombin time of blood: preliminary report of experimental and clinical studies. Proc. Staff Meet. Mayo Clin., 16: 388, 1941.
3.
Griffith, G.C. , Leak, D., AND Hegde, B.: Conservative anticoagulant therapy of acute myocardial infarction. Ann. Int. Med., 57: 254, 1962.
4.
Hilden, T., Iversen, K., Raaschou, F., AND Schwartz, M.: Anticoagulants in acute myocardial infarction. Lancet , 2: 327, 1961.
5.
Owren, P.A.: The results of anticoagulant therapy in Norway. Arch. Int. Med., 111: 240, 1963.
6.
Wright, I.S. : An evaluation of anticoagulant therapy for myocardial infarction. Lancet, 2: 654, 1962.
7.
Seaman, A.J. : An overview of anticoagulant therapy for coronary artery disease. Am. J. Med., 33: 717, 1962.
8.
Russek, H.I. , Zohman, B.L., White , L.G., AND Doerner, A.A.: Indications for bishydroxycoumarin (Dicumarol) in acute myocardial infarction. J. A. M. A., 145: 390, 1951.
9.
Russek, H.I.: Present status of anticoagulant therapy in acute myocardial infarction. Presented at theAmerican College of Cardiology, Los Angeles, February 27, 1963.
10.
Manchester, B.: The prevention of myocardial infarction. A. M. A. Arch. Int. Med., 100: 959, 1957.
11.
Bjerkelund, C. : The effectiveness of anticoagulant prophylaxis after myocardial infarction. In International Symposium, Anticoagulants and Fibrinolysins, p. 266, edited by R. MacMilan, and J. Mustard, Lea & Febiger , Philadelphia, 1961.
12.
The British Medical Research Council.Report of the Working Party on anticoagulant therapy in coronary thrombosis: An assessment of long-term anticoagulant administration after cardiac infarction . Brit. M. J., 1: 803, 1959.
13.
Borchgrevink, C.F.: Long-term anticoagulant therapy in angina pectoris and myocardial infarction, a clinical trial of intensive versus moderate treatment. Acta med. scandinav., 168 (suppl 359): 1, 1960.
14.
Borchgrevink, C.F.: Long-term anticoagulant therapy in angina pectoris: a follow-up study. Lancet, 1: 449, 1962.
15.
Kuhn, P., Van Ness, A., Jones, R., AND Bay, E.: Long-term anticoagulant therapy after acute myocardial infarction . Arch. Int. Med., 108: 884, 1961.
16.
Harvald, B. , Hilden, T., AND Lund, E.: Long-term anticoagulant therapy after myocardial infarction. Lancet, 2: 626, 1962.
17.
Seaman, A.J. , Griswold, H., Reaume, R., AND Ritzman, L.: Evaluation of randomized continuous prophylactic anticoagulant therapy for coronary artery disease by a double blindfold study technique. A progress report after seven years. Presented at the Western Association of Physicians, Carmel , California, February 1963.
18.
Binder, M.J. : Personal communication.
19.
Millikan, C.H. , Siekert, R.G., AND Shick, R.M.: Studies in cerebrovascular disease, use of anticoagulant drugs in treatment of insufficiency or thrombosis within basilar arterial system. Proc. Staff Meet. Mayo Clinic, 30: 116, 1955.
20.
Siekert, R.G. : Anticoagulant therapy. In Transactions of the Third Conference Held Under Auspices of the American Neurological Association and theAmerican Heart Association, p. 94. Grune & Stratton, Inc., New York, 1961.
21.
McDevitt, E.: Anticoagulant therapy, cerebral vascular disease. In Transactions of the Third Conference Held Under the Auspices of the American Neurological Association and theAmerican Heart Association , p. 90. Grune & Stratton, Inc., New York, 1961.
22.
Baker, R.W.: An evaluation of anticoagulant therapy in the treatment of cerebrovascular disease. Neurology, 11: 132, 1961.
23.
Fisher, C.M. : Anticoagulant therapy in cerebral thrombosis and cerebral embolism, a national cooperative study, interim report. Neurology, 11: 119, 1961.
24.
Greep, J.M.: Anticoagulants in the surgical clinic. In Proceedings of the Dijkzigt Conference on the Prevention of Thromboembolism in Surgery , Rotterdam, the Netherlands, p. 5. Excerpta Medica Foundation, Amsterdam, London, Milan, New York, 1961.
25.
Thies, H.A.: Thirteen years of post-operative thrombosis prophylaxis with coumarin derivatives . In Proceedings of the Dijkzigt Conference on the Prevention of Thromboembolism in Surgery, Rotterdam , the Netherlands, p. 18. Excerpta Medica Foundation, Amsterdam, London, Milan, New York, 1961.
26.
Matis, P.: Results of alternating anticoagulant prophylaxis in surgery. In Proceedings of the Dijkzigt Conference on the Prevention of Thromboembolism in Surgery, Rotterdam, the Netherlands, p. 22. Excerpta Medica Foundation, Amsterdam, London, Milan, New York, 1961.
27.
Sevitt, S.: Anticoagulant prophylaxis against venous thrombosis and pulmonary embolism in injured patients. In Proceedings of the Dijkzigt Conference on the Prevention of Thromboembolism in Surgery, Rotterdam, the Netherlands, p. 27. Excerpta Medica Foundation, Amsterdam, London, Milan, New York, 1961.
28.
Chalmers, D.G. : Seven years' experience with prophylactic anticoagulants in gynaecology. In Proceedings of the Dijkzigt Conference on the Prevention of Thromboembolism in Surgery, Rotterdam, the Netherlands, p. 37. Excerpta Medica Foundation, Amsterdam, London, Milan, New York, 1961.
29.
Stamm, H.: The prophylactic use of heparin in gynaecology and obstetrics. In Proceedings of the Dijkzigt Conference on the Prevention of Thromboembolism in Surgery, Rotterdam, the Netherlands, p. 41. Excerpta Medica Foundation, Amsterdam, London, Milan, New York, 1961.
30.
Quick, A.J. : Control of anticoagulant therapy, progress and problems. Arch. Int. Med., 111: 234, 1963 .
31.
Documenta Geigy Scientific Tables, Ed. 6, p. 582. Geigy Pharmaceuticals, Ardsley, New York, 1962.
32.
Owren, P.A. : Indications for anticoagulant therapy. New England J. Med., 268: 1173, 1963.
33.
Pastor, B.H. , AND Rodman, T.: Clinical problems arising from the laboratory control of anticoagulant therapy. Presented at the meeting of the American College of Physicians, Denver , April, 1963. Ann. Int. Med. 58: 713, 1963 (abstract).
34.
Vigran, I.M. : A new test for anticoagulant therapy. J. A. M. A.176: 188, 1961.
35.
Vigran, I.M. : Thrombotest, a simplified modification. Angiology, 14: 1963.
36.
Eliot, R.S. , Von Kaulla, K.N., AND Blount, S.G., JR.: Thromboelastographic studies with a twenty-four-hour schedule for subcutaneous heparin. A comparison of its efficiency with prothrombin depressing agents. Angiology , 24: 1206, 1961.
37.
Zweifler, A.J. : Study of thrombus growth; effect of heparin . J. Lab. & Clin. Med., 60: 254, 1962.
38.
Wessler, S. , AND Morris, L.E.: Studies in intravascular coagulation IV: The effect of heparin and Dicumarol on serum induced venous thrombosis . Circulation, 12: 553, 1955.
39.
Ware, A.B., AND Stragnell, R.: Anticoagulant therapy: elimination of some commonly occurring pitfalls . Ann. Int. Med., 46: 450, 1957.
40.
Crowell, J.W. , AND Read, W.L.: Hyperactivity of the blood coagulability control mechanism. A possible cause of irreversible shock. Am. J. Med., 19: 138, 1955.
41.
Luisada, A.A. AND Contro, S.: Experimental pulmonary edema following rapid carotid infusion: mechanism and therapy. Circulation Res., 1: 179, 1953.
42.
Green, J.P. , AND Nahum, L.H.: Effects of liver fractions on myocardial contractility. Circulation Res., 5: 634, 1957.
43.
Bloch, E.H. : In vivo microscopic observations of the circulating blood in acute myocardial infarction. Am. J. M. Sc., 229: 380, 1955.
44.
Moolten, S.E. , Vroman, L., AND Vroman, G.M.S.: Adhesiveness of blood platelets in thromboembolism and hemorrhagic disorders. Am. J. Clin. Path., 19: 814, 1949.
45.
Warren, R., AND Belko, J.S.: A comparison of heparin and bishydroxycoumarin (Dicumarol) as anticoagulants. Resistance to tissue thromboplastin. A. M. A. Arch. Surg. , 74: 50, 1957.
46.
McDonald, L. , AND Edgill, M.: Action of heparin in ischaemic heart disease . Lancet, 1: 844, 1961.
47.
Morrione, T.J. : The formation of collagen fibers by the action of heparin on soluble collagen: an electron microscope study. J. Exper. Med., 96: 107, 1952.
48.
McGovern, V.J. : Reactions to injury of vascular endothelium with special reference to the problem of thrombosis. J. Path. & Bact., 69: 283, 1955.
49.
Griffith, G.C. : Anticoagulants in cardiovascular disease. J. Am. Geriatrics Soc., 2: 719, 1954.
50.
Fullerton, H.W., Davie, W.J.A., AND Anastasopoules , G.: Relationship of alimentary lipemia to blood coagulability. Brit. M. J. , 2: 250, 1953.
51.
Loughry, C.W. , AND Cole, J.W.: In vitro effect of autologous lipemia plasma platelet suspension. Proc. Soc. Exper. Biol. &Med., 85: 631, 1954.
52.
Swank, R.L. : Effect of high fat feedings on viscosity of the blood. Science, 120: 427, 1954.
53.
Cullen, C.F. , AND Swank, R.L.: Intravascular aggregation and adhesiveness of the blood elements associated with alimentary lipemia and injection of large molecular substances. Circulation, 9: 335, 1954.
54.
Kuo, P.T., AND Joyner, C.R., JR.: Angina pectoris induced by fat ingestion in patients with coronary artery disease. Ballistocardiographic and electrocardiographic findings. J. A. M. A., 158: 1008, 1955.
55.
Bornstein, J. : Inhibition of enzymes and lipoproteins. Biochim. et biophys. acta, 20: 522, 1956.
George, E.P. , Hall, G.V., AND Farkas, G.S.: Lipaemic clearing action of artificial anticoagulants. Nature, London, 187: 782, 1960.
58.
Blake, T.M. , Wood, E.G., JR., O'Moore , D., AND Neel, R.G.: The vasodilating effects of coumarin derivatives. Am. J. M. Sc., 244: 598, 1962.
59.
Escudero, J. , McDevitt, E., AND Wright, I.S.: Dicumarol, Coumadin, Marcumar, and Tromexan: comparative study of their action on the clot as registered by the thromboelastogram . Circulation , 20: 405, 1959.
60.
Griffith, G.C. , Zinn, W.J., Engelberg , H., Dooley, J.V. AND Anderson, R.: Heparin versus heparin-bishydroxycoumarin anticoagulant therapy. J. A. M. A., 9: 79, 1960.
61.
Nichol, E.S. , Phillips, W.C., AND Casten, G.G.: Virtue of prompt anticoagulant therapy in impending myocardial infarction: experiences with 318 patients during a 10-year period. Ann. Int. Med. , 50: 1158, 1959